Job/Unit: O21420
/KAP1
Date: 10-01-13 15:44:07
Pages: 8
I. Rodríguez, M. I. Calaza, C. Cativiela
FULL PAPER
3 H, OCH3), 3.61–3.79 (m, 1 H, Hβ), 4.53 (d, J = 8.8 Hz, 0.55 H,
Hα), 4.62 (d, J = 8.7 Hz, 0.45 H, Hα), 7.16–7.36 (m, 5 H, Ar) ppm.
13C NMR (100 MHz, CDCl3, duplicate signals observed for all car-
bon atoms): δ = 26.04/26.90 (Cδ-CH3), 27.16/28.20 (Cδ-CH3),
28.44/28.62 (tBu CH3), 43.07/43.62 (Cβ), 43.71/44.51 (Cγ), 51.20/
51.34 (OCH3), 60.52/61.18 (Cδ), 66.70/66.84 (Cα), 79.68/80.24 (tBu
C), 127.45/127.51 (Ar), 127.96/128.00 (Ar), 128.38/128.41 (Ar),
136.74/136.77 (Ar), 152.47/154.26 (tBuOCO), 172.15/172.23
(CO2CH3) ppm. HRMS (ESI): calcd. for C19H27NO4 [M + H]+
334.2013; found 334.1993; calcd. for C19H27NNaO4 [M + Na]+
356.1832; found 356.1828.
[9]
a) C. Melis, G. Bussi, S. C. R. Lummis, C. Molteni, J. Phys.
Chem. B 2009, 113, 12148–12153; b) D. A. Dougherty, Chem.
Rev. 2008, 108, 1642–1653; c) D. A. Dougherty, J. Org. Chem.
2008, 73, 3667–3673; d) S. C. R. Lummis, D. L. Beene, L. W.
Lee, H. A. Lester, R. W. Broadhurst, D. A. Dougherty, Nature
2005, 438, 248–252.
[10]
a) S. A. Alonso de Diego, M. Gutiérrez-Rodríguez, M. J.
Pérez de Vega, R. González-Muñiz, R. Herranz, M. Martín-
Martínez, E. Cenarruzabeitia, D. Frechilla, J. Del Río, M. L.
Jimeno, M. T. García-López, Bioorg. Med. Chem. Lett. 2006,
16, 3396–3400; b) P. W. R. Harris, M. A. Brimble, V. J. Muir,
M. Y. H. Lai, N. S. Trotter, D. J. Callis, Tetrahedron 2005, 61,
10018–10035; c) R. T. Shuman, R. B. Rothenberger, C. S.
Campbell, G. F. Smith, D. S. Gifford-Moore, J. W. Paschal,
P. D. Gesellchen, J. Med. Chem. 1995, 38, 4446–4453.
a) M. M. Stec, Y. Bo, P. P. Chakrabarti, L. Liao, M. Ncube, N.
Tamayo, R. Tamir, N. R. Gavva, J. J. S. Treanor, M. H. Nor-
man, Bioorg. Med. Chem. Lett. 2008, 18, 5118–5122; b) Y. Y.
Bo, P. P. Chakrabarti, N. Chen, H. Liao, M. H. Norman, M.
Stec, N. Tamayo, X. Wang, U. S. Patent Appl. US
20060183745, 2006 [Chem. Abstr. 2006, 145, 230648].
a) M. A. Brimble, P. W. R. Harris, F. Sieg, U. S. Patent Appl.
US 20080145335, 2008 [Chem. Abstr. 2008, 149, 79898]; b)
M. A. Brimble, P. W. R. Harris, F. Sieg, PCT Int. Patent Appl.
WO2006127702, 2006 [Chem. Abstr. 2006, 146, 28049].
P. Ciapetti, F. Chery-Mozziconacci, C. G. Wermuth, S. Ropp,
C. Morice, B. Giethlen, F. Leblanc, M. Schneider, PCT Int.
Patent Appl. WO2010004394, 2010 [Chem. Abstr. 2010, 152,
169004].
Q. Xia, B. Ganem, Tetrahedron Lett. 2002, 43, 1597–1598.
V. W. Magaard, R. M. Sanchez, J. W. Bean, M. L. Moore, Tet-
rahedron Lett. 1993, 34, 381–384.
a) B. J. van Lierop, W. R. Jackson, A. J. Robinson, Tetrahedron
2010, 66, 5357–5366; b) C. M. Griffiths-Jones, D. W. Knight,
Tetrahedron 2010, 66, 4150–4166; c) J. Elaridi, W. R. Jackson,
A. J. Robinson, Tetrahedron: Asymmetry 2005, 16, 2025–2029;
d) C. M. Haskins, D. W. Knight, Chem. Commun. 2002, 2724–
2725.
I. Rodríguez, M. I. Calaza, A. I. Jiménez, C. Cativiela, Tetrahe-
dron 2012, 68, 9578–9582.
a) E. Juaristy, V. A. Soloshonok (Eds.), Enantioselective Syn-
thesis of β-Amino Acids, Wiley, Hoboken, 2005; b) B. E. Sleebs,
T. T. Van Nguyen, A. B. Hughes, Org. Prep. Proced. Int. 2009,
41, 429–478; c) S. Abele, D. Seebach, Eur. J. Org. Chem. 2000,
1–15.
C. Francavilla, E. Low, S. Nair, B. Kim, T. P. Shiau, D. Deba-
bov, C. Celeri, N. Alvarez, A. Houchin, P. Xu, R. Najafi, R.
Jain, Bioorg. Med. Chem. Lett. 2009, 19, 2731–2734.
F. W. Bollinger, L. D. Tuma, Synlett 1996, 407–413.
Although 3 and 4 are stable for purification by silica gel
chromatography, the crude materials were employed through-
out the synthesis of 5.
M. Takemura, K. Higashi, H. Fujiwara, M. Sato, M. Furu-
kawa, Chem. Pharm. Bull. 1985, 33, 5190–5196.
D. L. Comins, A. Dehghani, Tetrahedron Lett. 1992, 33, 6299–
6302.
A. García Martínez, R. Martínez Álvarez, J. Arranz Aguirre,
L. R. Subramanian, J. Chem. Soc. Perkin Trans. 1 1986, 1595–
1598.
W. J. Scott, J. K. Stille, J. Am. Chem. Soc. 1986, 108, 3033–
3040.
R. Kuwano, D. Karube, Y. Ito, Tetrahedron Lett. 1999, 40,
9045–9049.
P. Huy, J.-M. Neudörfl, H.-G. Schmalz, Org. Lett. 2011, 13,
216–219.
Supporting Information (see footnote on the first page of this arti-
1
cle): H and 13C NMR spectra of compounds 2, 5–10.
[11]
Acknowledgments
The authors thank Dr. A. I. Jiménez for helpful discussions and
comments on the manuscript. Financial support from the Minis-
terio de Ciencia e Innovación – FEDER (grant CTQ2010-17436;
FPI fellowship to I. R.), and the Gobierno de Aragón – FSE (re-
search group E40) is gratefully acknowledged.
[12]
[13]
[1] a) P. Chakrabarti, D. Pal, Prog. Biophys. Mol. Biol. 2001, 76,
1–102; b) M. W. MacArthur, J. M. Thornton, J. Mol. Biol.
1991, 218, 397–412.
[2] a) D. Pal, P. Chakrabarti, J. Mol. Biol. 1999, 294, 271–288; b)
D. E. Stewart, A. Sarkar, J. E. Wampler, J. Mol. Biol. 1990,
214, 253–260.
[3] a) G. Ruiz-Gómez, J. D. A. Tyndall, B. Pfeiffer, G. Abbenante,
D. P. Fairlie, Chem. Rev. 2010, 110, PR1–PR41; b) G. D. Rose,
L. M. Glerasch, J. A. Smith, Adv. Protein Chem. 1985, 37, 1–
109.
[4] a) P. Sarkar, C. Reichman, T. Saleh, R. B. Birge, C. G. Kalod-
imos, Mol. Cell 2007, 25, 413–426, and references cited therein;
b) S. Wawra, G. Fischer, “Amide Cis-Trans Isomerization in
Peptides and Proteins” in Cis-Trans Isomerization in Biochemis-
try (Ed.: C. Dugave), Wiley-VCH, Weinheim, 2006, pp. 167–
193; c) C. Dugave, L. Demange, Chem. Rev. 2003, 103, 2475–
2532; d) W. J. Wedemeyer, E. Welker, H. A. Scheraga, Biochem-
istry 2002, 41, 14637–14644; e) M. S. P. Sansom, H. Weinstein,
Trends Pharmacol. Sci. 2000, 21, 445–451.
[5] a) F. J. Sayago, P. Laborda, M. I. Calaza, A. I. Jiménez, C. Ca-
tiviela, Eur. J. Org. Chem. 2011, 2011–2028; b) C. Cativiela,
M. Ordóñez, Tetrahedron: Asymmetry 2009, 20, 1–63; c) M. I.
Calaza, C. Cativiela, Eur. J. Org. Chem. 2008, 3427–3448; d)
P. Karoyan, S. Sagan, O. Lequin, J. Quancard, S. Lavielle, G.
Chassaing, “Substituted Prolines: Syntheses and Applications
in Structure-Activity Relationship Studies of Biologically
Active Peptides” in Targets in Heterocyclic Systems: Chemistry
and Properties (Eds.: O. A. Attanasi, D. Spinelli), Royal Society
of Chemistry, Cambridge, 2005, vol. 8, pp. 216–273; e) C. Cati-
viela, M. D. Díaz-de-Villegas, Tetrahedron: Asymmetry 2000,
11, 645–732.
[6] a) L. Moroder, C. Renner, J. J. Lopez, M. Mutter, G. Tuchsch-
erer, “Tailoring the Cis-Trans Isomerization of Amides” in Cis-
Trans Isomerization in Biochemistry (Ed.: C. Dugave), Wiley-
VCH, Weinheim, 2006, pp. 225–259; b) Y. Che, G. R. Marshall,
Biopolymers 2006, 81, 392–406.
[7] S. S. A. An, C. C. Lester, J.-L. Peng, Y.-J. Li, D. M. Rothwarf,
E. Welker, T. W. Thannhauser, L. S. Zhang, J. P. Tam, H. A.
Scheraga, J. Am. Chem. Soc. 1999, 121, 11558–11566.
[8] a) U. Arnold, Biotechnol. Lett. 2009, 31, 1129–1139; b) G. R.
Marshall, J. A. Feng, D. J. Kuster, Biopolymers (Pept. Sci.)
2008, 90, 259–277; c) U. Arnold, M. P. Hinderaker, J. Köditz,
R. Golbik, R. Ulbrich-Hofmann, R. T. Raines, J. Am. Chem.
Soc. 2003, 125, 7500–7501.
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
a) S. Hanessian, R. Margarita, A. Hall, X. Luo, Tetrahedron
Lett. 1998, 39, 5883–5886; b) D. J. Aldous, M. G. B. Drew,
E. M.-N. Hamelin, L. M. Harwood, A. B. Jahans, S. Thurairat-
nam, Synlett 2001, 1836–1840; c) C. M. Griffiths-Jones, D. W.
Knight, Tetrahedron 2011, 67, 8515–8528.
6
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0